An interventional study of Tailored yoga therapy. and Functional movement. in Attention-Deficit Hyperactivity Disorder Symptoms and Attention-Deficit Hyperactivity Disorder, sponsored by King's College London. Active, not recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-21.
Sponsored by King's College London · Not applicable, Interventional, and Treatment
This study will explore the feasibility, acceptability, and potential benefits of a group-based tailored yoga programme designed for adults experiencing symptoms of attention-deficit hyperactivity disorder. The yoga intervention will be compared to an active control (group-based functional movement classes).
The primary aim of the study is to test the feasibility and acceptability of a tailored, group-based yoga intervention for adults with attention-deficit hyperactivity disorder, by monitoring recruitment, engagement, and completion rates, and through obtaining qualitative feedback from participants at the end of the intervention.
A secondary aim is to explore whether the yoga intervention is associated with improvements in attention-deficit hyperactivity disorder and related symptoms (i.e., anxiety, depression), quality of life, and general functioning, compared to a control intervention (group-based functional movement sessions). The secondary outcomes will be assessed with self-report questionnaires at the start, middle and end of the yoga and control interventions, and three months after completion of the interventions.
The investigators will also examine aspects of cognitive and physiological functioning through laboratory testing at the start and end of the intervention, focusing on measures of autonomic activation (e.g., the 'fight or flight response), bodily awareness, attention, and response inhibition. Physiological functioning, such as sleep quality, activity levels, and heart rate, will be monitored throughout the six-week study with wearable devices (e.g., Fitbit activity trackers), to provide longer-term, real-world insights into the possible benefits of the intervention.
The investigators will explore whether the yoga intervention is associated with improvements in attention-deficit hyperactivity disorder and related symptoms/abilities, including emotional regulation, social behaviour, attention, focus, interoception and stress reactivity. The investigators will also explore whether the yoga intervention is linked with improved bodily stress markers (heart rate variability), sleep, and physical activity.
This feasibility randomised controlled trial will include 20 participants who will be randomly allocated (1:1) to either the group-based tailored yoga therapy intervention (n=10), or a group-based functional movement class (n=10). The latter will be a structured class focusing on light strength, mobility and flexibility.
All participants will attend an initial in-person laboratory testing session at the start and end of the 6-week intervention. Each week, both intervention group and control group will attend an in-person one-hour group session. Each week, participants will be asked to practice at least twice, using a 20-minute video recording on demand from home. Outcomes will be measured using self-report, lab-based, and digital wearable measures.
1,514 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 255 are open to participants now.
This study's planned enrollment of 20 is below the median of 72 across 1,207 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.
Browse Attention Deficit Disorder with Hyperactivity studies →King's College London is the lead sponsor of 506 studies on the registry; 125 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
A 6-week group-based yoga programme designed for people experiencing attention-deficit hyperactivity disorder symptoms.
Behavioral: Tailored yoga therapy.
Participants will receive an active control of functional movement.
Behavioral: Functional movement.
Participants in this arm will participate in a six-week study. They will attend one hour-long group-based in-person session per week, as well as practising from home at least twice weekly following along an online video (which will be a practice of what was learnt in-person that week). Each group yoga session will start with some Pranayama (yogic breathwork) to engage participants' attention and to help them focus. The intervention will progress from purely activating yogic breathwork techniques, to some calming and grounding techniques to aid relaxation, bodily awareness and to reduce stress. Sessions will also involve some faster movements to align the body with typically faster mental activities as seen within individuals with ADHD. Some sessions may progress to include some mindful somatic movements and some longer held poses to enhance relaxation and tension release. Towards the end of the intervention there will be longer opportunities for mindful awareness through meditation.
Participants in this arm will similarly participate in a six-week study. They will attend one hour-long group-based in-person session per week, as well as practising from home at least twice weekly following along an online video (which will be a practice of what was learnt in-person that week). The functional movement control sessions will serve as an exercise class, with educational aspects. All sessions will follow a similar structure of light strength exercises, mobility exercises and end with some flexibility exercises. This control condition was selected to control for the physical aspects the yoga intervention, allowing us to isolate the possible benefits of yoga due to breathwork and mindfulness.
Feasibility outcomes.
The investigators will monitor recruitment, engagement and completion rates to assess feasibility, and will obtain qualitative participant feedback at the end of the intervention.
Time frame: From enrolment to the 3-month follow-up.
Exploratory assessment of self-reported change in attention-deficit hyperactivity disorder.
The outcomes will be assessed with self-report questionnaires at the start, middle and end of the yoga and control interventions, and 3-months after completion of the intervention.
Time frame: From enrolment to the 3-month follow-up.
Changes in self-reported general health symptoms.
The investigators will assess anxiety levels (Generalized Anxiety Disorder - 7), interoceptive awareness (Multidimensional Assessment of Interoceptive Awareness), health (Patient Health Questionnaire - 8), quality of life (36-item Short Form survey), and social functioning (Work \& Social Adjustment Scale).
Time frame: From enrolment to the 3-month follow-up.
Laboratory-based assessments to test changes in autonomic arousal.
The investigators will examine aspects of physiological functioning through laboratory testing at the start and end of the intervention, focusing on measures of autonomic activation (e.g., the 'fight or flight response), through electrocardiogram and skin conductance.
Time frame: Baseline to post-intervention.
Laboratory-based assessments to test changes in executive functioning attention.
The investigators will test attention through The Sustained Attention Task.
Time frame: Baseline to post-intervention.
Laboratory-based assessments to test changes in executive functioning inhibition control.
The investigators will test response inhibition through the Stop Signal Task.
Time frame: Baseline to post-intervention.
Wearable-derived measures of physiological functioning.
Physiological functioning will be monitored throughout the six-week study and follow-up period with wearable devices (Fitbit Inspire 3 activity tracker watches).
Time frame: From enrolment to the 3-month follow-up.
This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Attention Deficit Disorder with Hyperactivity→
King's College London